We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.35B
AUM Growth
+$25.5M
Cap. Flow
+$32.7M
Cap. Flow %
2.42%
Top 10 Hldgs %
12.05%
Holding
2,121
New
584
Increased
441
Reduced
528
Closed
563

Top Sells

Rank Stock Value
1
LMND icon
Lemonade
LMND
+$4.64M
2
MGNI icon
Magnite
MGNI
+$3.66M
3
RELY icon
Remitly
RELY
+$3.66M
4
MNRO icon
Monro
MNRO
+$3.65M
5
VGR
Vector Group Ltd.
VGR
+$3.32M

Sector Composition

Rank Sector Weight
1 Technology 16.19%
2 Healthcare 13.13%
3 Financials 12.64%
4 Consumer Discretionary 12.16%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CACC icon
976
Credit Acceptance
CACC
$6.08B
$444K 0.03%
946
-117
-11% -$54.2K
TXG icon
977
10x Genomics
TXG
$6.61B
$444K 0.03%
+30,922
New +$488K
OTEX icon
978
Open Text
OTEX
$6.04B
$443K 0.03%
+15,647
New +$482K
DIA icon
979
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.5B
$442K 0.03%
1,038
-215
-17% -$93.1K
ONIT
980
Onity Group
ONIT
$332M
$442K 0.03%
14,389
-5,346
-27% -$165K
GNW icon
981
Genworth Financial
GNW
$3.71B
$441K 0.03%
63,145
-26,138
-29% -$188K
STNE icon
982
StoneCo
STNE
$2.58B
$440K 0.03%
55,253
-8,363
-13% -$84.8K
PRAX icon
983
Praxis Precision Medicines
PRAX
$10.1B
$437K 0.03%
+5,682
New +$411K
VMC icon
984
Vulcan Materials
VMC
$36.9B
$437K 0.03%
1,697
-473
-22% -$127K
ZNTL icon
985
Zentalis Pharmaceuticals
ZNTL
$302M
$437K 0.03%
144,170
-464,415
-76% -$1.52M
MGPI icon
986
MGP Ingredients
MGPI
$375M
$436K 0.03%
11,084
-1,050
-9% -$57.1K
MKTX icon
987
MarketAxess Holdings
MKTX
$5.72B
$436K 0.03%
+1,930
New +$508K
TITN icon
988
Titan Machinery
TITN
$445M
$436K 0.03%
+30,867
New +$447K
IDYA icon
989
IDEAYA Biosciences
IDYA
$3.56B
$435K 0.03%
16,913
+1,850
+12% +$52.4K
USB icon
990
US Bancorp
USB
$99.6B
$435K 0.03%
+9,091
New +$447K
HUN icon
991
Huntsman Corp
HUN
$1.77B
$434K 0.03%
+24,074
New +$501K
CRBP icon
992
Corbus Pharmaceuticals
CRBP
$190M
$432K 0.03%
+36,647
New +$615K
MTD icon
993
Mettler-Toledo International
MTD
$28.6B
$431K 0.03%
+352
New +$459K
BFH icon
994
Bread Financial
BFH
$4.38B
$427K 0.03%
6,988
-4,443
-39% -$251K
CRSR icon
995
Corsair Gaming
CRSR
$1.55B
$427K 0.03%
+64,651
New +$449K
PBPB
996
DELISTED
Potbelly
PBPB
$427K 0.03%
45,379
-49,386
-52% -$448K
PCTY icon
997
Paylocity
PCTY
$7.98B
$427K 0.03%
2,143
-312
-13% -$59.7K
SILC icon
998
Silicom
SILC
$242M
$426K 0.03%
26,143
-1,339
-5% -$19K
IYT icon
999
iShares US Transportation ETF
IYT
$2.28B
$425K 0.03%
+6,294
New +$445K
NATH icon
1000
Nathan's Famous
NATH
$402M
$425K 0.03%
5,403
+1,587
+42% +$134K

Similar funds

GSA Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, GSA Capital Partners held 2,121 positions worth $1.35B, up 1.9% from $1.32B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners's Q4 2024 filing shows 584 new, 441 increased, 528 reduced and 563 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M. The largest sale was Lemonade, an estimated $4.64M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • GSA Capital Partners's largest Q4 2024 buy was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M.
  • GSA Capital Partners added most to Frontline in Q4 2024, an estimated $5.7M increase.
  • GSA Capital Partners's biggest Q4 2024 reduction was Lemonade, cutting an estimated $4.64M.
  • GSA Capital Partners fully exited Monro in Q4 2024, selling an estimated $3.65M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.35B portfolio in Q4 2024.
  • GSA Capital Partners opened 584 new positions and closed 563 in Q4 2024.
  • GSA Capital Partners's portfolio value rose 1.9% quarter-over-quarter to $1.35B.

Based on GSA Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.